참고문헌
- Alves CC, Carneiro F, Hoefler H, et al (2009). Role of the epithelialmesenchymal transition regulator Slug in primary human cancers. Front Biosci, 14, 3035-50.
- Berx G, Becker KF, Hofler H, et al (1998). Mutations of the human E-cadherin (CDH1) gene. Hum Mutat, 12, 226-37. https://doi.org/10.1002/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-D
- Birchmeier W, Behrens J (1994). Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta, 1198, 11-26.
- Chen CL, Liu SS, Ip SM, et al (2003). E-cadherin expression is silenced by DNA methylation in cervical cancer cell lines and tumours. Eur J Cancer, 39, 517-23. https://doi.org/10.1016/S0959-8049(02)00175-2
- Cheng CW, Wu PE, Yu JC, et al (2001). Mechanisms of inactivation of E-cadherin in breast carcinoma: modification of the two-hit hypothesis of tumor suppressor gene. Oncogene, 20, 3814-23. https://doi.org/10.1038/sj.onc.1204505
- Corn PG, Heath EI, Heitmiller R, et al (2001). Frequent hypermethylation of the 5' CpG island of E-cadherin in esophageal adenocarcinoma. Clin Cancer Res, 7, 2765-9.
- Esteller M (2002). The coming of age of DNA methylation in medicine in the genomics and postgenomics era. Clin Immunol, 103, 213-6. https://doi.org/10.1006/clim.2002.5216
- Fei QY, Zhang HT, Chen XF, et al (2002). Defected expression of E-cadherin in non-small cell lung cancer. Lung Cancer, 37, 142-52.
- Gamallo C, Palacios J, Suarez A, et al (1993). Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol, 142, 987-93.
- Graff JR, Herman JG, Lapidus RG, et al (1995). E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res, 55, 5195-9.
- Guarino M (2007). Epithelial-mesenchymal transition and tumour invasion. Int J Biochem Cell Biol, 12, 2153-60.
- Herman JG, Graff JR, Myohanen S, et al (1996). Methylationspecific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA, 93, 9821-6. https://doi.org/10.1073/pnas.93.18.9821
- Hirohashi S (1998). Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol, 153, 333-9. https://doi.org/10.1016/S0002-9440(10)65575-7
- Hiraguri S, Godfrey T, Nakamura H, et al (1998). Mechanisms of inactivation of E-cadherin in breast cancer cell lines. Cancer Res, 58, 1972-7.
- Kanai Y, Ushijima S, Hui AM, et al (1997). The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas. Int J Cancer, 71, 355-9. https://doi.org/10.1002/(SICI)1097-0215(19970502)71:3<355::AID-IJC8>3.0.CO;2-X
- Kase S, Sugio K, Yamazaki K, et al (2000). Expression of E-cadherin and beta-catenin in human non-small cell lung cancer and the clinical significance. Clin Cancer Res, 6, 4789-96.
- Leonhardt H, Cardoso MC (2000). DNA methylation, nuclear structure, gene expression and cancer. J Cell Biochem, 35, 78-83.
- Li LC. Zhao H. Nakajima K, et al (2001). Methylation of the E-cadherin gene promoter correlates with progression of prostate cancer. J Urol, 166, 705-9. https://doi.org/10.1016/S0022-5347(05)66047-8
- Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T) Method. Methods, 25, 402-8. https://doi.org/10.1006/meth.2001.1262
- Machado JC, Oliveira C, Carvalho R, et al (2001). E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene, 20, 1525-8. https://doi.org/10.1038/sj.onc.1204234
- Margineanu E, Cotrutz CE, Cotrutz C (2008). Correlation between E-cadherin abnormal expressions in different types of cancer and the process of metastasis. Rev Med Chir Soc Med Nat Iasi, 112, 432-6.
- Mountain CF (1997). Revisions in the international system for staging lung cancer. Chest, 111, 1710-7. https://doi.org/10.1378/chest.111.6.1710
- Oka H, Shiozaki H, Kobayashi K, et al (1993). Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res, 53, 1696-701.
- Schipper JH, Frixen UH, Behrens J, et al (1991). E-cadherin expression in squamous cell carcinomas of head and neck: Inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res, 51, 6328-37.
- Shimoyama Y, Hirohashi S (1991). Cadherin intercellular adhesion molecule in hepatocellular carcinomas: Loss of E-cadherin expression in an undifferentiated carcinoma. Cancer Lett, 57, 131-5. https://doi.org/10.1016/0304-3835(91)90206-W
- Shimoyama Y, Hirohashi S (1991). Expression of E- and P-cadherin in gastric carcinomas. Cancer Res, 51, 2185-92.
- Shiozaki H, Tahara H, Oka H, et al (1991). Expression of immunoreactive E-cadherin adhesion molecules in human cancers. Am J Pathol, 139, 17-23.
- Tamura G, Yin J, Wang S, et al (2000). E-cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst, 92, 569-73. https://doi.org/10.1093/jnci/92.7.569
- Tamura G, Yin J, Wang S, et al (2000). E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst (Bethesda), 92, 569-73.
- Tsao SW, Liu Y, Wang X, et al (2003). The association of E-cadherin expression and the methylation status of the E-cadherin gene in nasopharyngeal carcinoma cells. Eur J Cancer, 39, 524-31. https://doi.org/10.1016/S0959-8049(02)00494-X
- Yoshiura K, Kanai Y, Ochiai A, et al (1995). Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc Natl Acad Sci USA, 9, 7416-9.
- Zhang HT, Chen XF, Wang MH, et al (2004). Defective expression of transforming growth factor beta receptor type II is associated with CpG methylated promoter in primary non-small cell lung cancer. Clin Cancer Res, 10, 2359-67. https://doi.org/10.1158/1078-0432.CCR-0959-3
- Zochbauer-Muller S, Fong KM, Virmani AK, et al (2001). Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res. 2001 Jan 1;61(1):249-55.
피인용 문헌
- Loss of Expression and Aberrant Methylation of the CDH1 (E-cadherin) Gene in Breast Cancer Patients from Kashmir vol.15, pp.15, 2014, https://doi.org/10.7314/APJCP.2014.15.15.6397
- E-cadherin gene methylation in lung cancer vol.35, pp.9, 2014, https://doi.org/10.1007/s13277-014-2076-9
- The clinicopathological significance and potential drug target of E-cadherin in NSCLC vol.36, pp.8, 2015, https://doi.org/10.1007/s13277-015-3298-1
- gene increase the risk of lung cancer? A meta-analysis pp.17597706, 2018, https://doi.org/10.1111/1759-7714.12900